Cargando…
BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
Targeting bromodomain and extra-terminal domain (BET) proteins has shown a promising therapeutic effect on melanoma. The development of strategies to better kill melanoma cells with BET inhibitor treatment may provide new clinical applications. Here, we used a drug synergy screening approach to comb...
Autores principales: | Zeng, Furong, Li, Yayun, Meng, Yu, Sun, Huiyan, He, Yi, Yin, Mingzhu, Chen, Xiang, Deng, Guangtong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981764/ https://www.ncbi.nlm.nih.gov/pubmed/36720918 http://dx.doi.org/10.1038/s12276-023-00936-y |
Ejemplares similares
-
EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
por: Deng, Guangtong, et al.
Publicado: (2022) -
BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
por: Deng, Guangtong, et al.
Publicado: (2020) -
Nomogram based on autophagy related genes for predicting the survival in melanoma
por: Deng, Guangtong, et al.
Publicado: (2021) -
The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022) -
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Veppil Muralidharan, Somsundar, et al.
Publicado: (2017)